J1611 HCPCS code: Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
J1611 is the HCPCS Level II code for injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg. In 2024 Medicare paid an average of $95.74 per service for J1611 across 6,115 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 2 per day on outpatient hospital claims. Medicare volume rose 247% from 2023 to 2024 (1,764 to 6,115 services). In 2024, about 185 clinicians billed Medicare for J1611 for 5,217 beneficiaries; Florida, Minnesota, Arizona accounted for 85% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-01-01 |
| Last action effective | 2023-01-01 |
Who bills J1611 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 185 |
| Medicare beneficiaries | 5,217 |
| States with claims | 9 |
| Share of services in top 3 states (Florida, Minnesota, Arizona) | 85% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1611, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 1,764 | 1,668 | $117.38 | $93.26 |
| 2024 | 6,115 | 5,217 | $120.24 | $95.74 |
States with the most J1611 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 2,647 | $96.05 |
| Minnesota | 1,900 | $95.86 |
| Arizona | 615 | $95.28 |
| Texas | 474 | $95.21 |
| Alabama | 241 | $95.68 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 2 | Prescribing Information |
| practitioner claims | 2 | Prescribing Information |
What changed for J1611
- 2023-01-01: J1611 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1611?
J1611 is the HCPCS Level II code for injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg. Short descriptor: "Inj glucagon hcl, fresenius".
How much does Medicare pay for J1611?
In 2024, the average Medicare payment was $95.74 per service (average allowed $120.24).
Does Medicare cover J1611?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J1611 can be billed per day?
2 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related J16 codes
- J1600 — Injection, gold sodium thiomalate, up to 50 mg
- J1602 — Injection, golimumab, 1 mg, for intravenous use
- J1610 — Injection, glucagon hydrochloride, per 1 mg
- J1612 — Injection, glucagon (gvoke), 0.01 mg
- J1620 — Injection, gonadorelin hydrochloride, per 100 mcg
- J1626 — Injection, granisetron hydrochloride, 100 mcg
- J1627 — Injection, granisetron, extended-release, 0.1 mg
- J1628 — Injection, guselkumab, 1 mg
- J1630 — Injection, haloperidol, up to 5 mg
- J1631 — Injection, haloperidol decanoate, per 50 mg
- J1632 — Injection, brexanolone, 1 mg
- J1640 — Injection, hemin, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1611
- Watch J1611 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1611
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.